Bioeconomy Capital

Parse Biosciences is a biotechnology company specializing in single-cell analysis and sequencing solutions. Founded in 2018 and based in Seattle, Washington, the company focuses on developing innovative technologies that simplify the sequencing process for researchers. By employing combinatorial cDNA barcoding directly within cells, Parse Biosciences eliminates the necessity for complex and costly microfluidic instruments. This technology allows for the fixing, freezing, and storage of samples, enabling researchers to conduct experiments with samples collected on different dates in a single run. This capability enhances sample handling and minimizes errors, ultimately improving the accuracy of results. The company aims to increase gene detection in individual cells while addressing common challenges associated with single-cell sequencing, thereby advancing research in various scientific fields.

Tandem PV, Inc. is a manufacturer of advanced photovoltaic cells that combines perovskite and silicon technologies to enhance solar panel efficiency. Established in 2016 and based in Palo Alto, California, the company, originally known as Iris Photovoltaics, rebranded in February 2018. Tandem PV specializes in mechanically-stacked perovskite-silicon tandem solar panels, which offer significant improvements in efficiency and performance. By integrating perovskite photovoltaics with traditional silicon technology, Tandem PV aims to provide a substantial increase in the value and market potential of solar energy while also reducing the costs associated with installed systems. The company's innovations position it as a key player in the renewable energy sector, contributing to the advancement of solar technology.

Arzeda Corporation is a synthetic biology company based in Seattle, Washington, that focuses on the development and manufacture of enzymes and specialty chemical products. Established in 2008, Arzeda employs intelligent protein design technology, integrating physics-based methodologies with artificial intelligence to create innovative designer proteins and enzymes. Its product portfolio caters to various industries, including polymers, pharmaceuticals, and industrial chemicals, enabling clients to access high-performance solutions that also emphasize cost-effectiveness and sustainability.

Parse Biosciences is a biotechnology company specializing in single-cell analysis and sequencing solutions. Founded in 2018 and based in Seattle, Washington, the company focuses on developing innovative technologies that simplify the sequencing process for researchers. By employing combinatorial cDNA barcoding directly within cells, Parse Biosciences eliminates the necessity for complex and costly microfluidic instruments. This technology allows for the fixing, freezing, and storage of samples, enabling researchers to conduct experiments with samples collected on different dates in a single run. This capability enhances sample handling and minimizes errors, ultimately improving the accuracy of results. The company aims to increase gene detection in individual cells while addressing common challenges associated with single-cell sequencing, thereby advancing research in various scientific fields.

Parse Biosciences is a biotechnology company specializing in single-cell analysis and sequencing solutions. Founded in 2018 and based in Seattle, Washington, the company focuses on developing innovative technologies that simplify the sequencing process for researchers. By employing combinatorial cDNA barcoding directly within cells, Parse Biosciences eliminates the necessity for complex and costly microfluidic instruments. This technology allows for the fixing, freezing, and storage of samples, enabling researchers to conduct experiments with samples collected on different dates in a single run. This capability enhances sample handling and minimizes errors, ultimately improving the accuracy of results. The company aims to increase gene detection in individual cells while addressing common challenges associated with single-cell sequencing, thereby advancing research in various scientific fields.

Lumen Bioscience, Inc. is a biotechnology company focused on developing therapeutic biologics for oral delivery. Established in 2017 and based in Seattle, Washington, the company utilizes Spirulina, a blue-green algae, as an industrial-scale production platform for manufacturing high-value molecules. Lumen Bioscience aims to transform the biologics industry by developing biologic drugs more rapidly and cost-effectively than traditional methods. The company offers expertise in synthetic biology, protein design, immunology, bioreactor engineering, and cell physiology, catering to the food, cosmetics, and healthcare sectors. By addressing prevalent diseases that currently lack effective treatments, Lumen Bioscience strives to provide clinicians with innovative therapeutics that were previously inaccessible within the biopharmaceutical landscape.

RoosterBio, Inc. is a biotechnology company specializing in the development of mesenchymal stem cells (MSCs) for the regenerative medicine sector. Founded in 2012 and headquartered in Frederick, Maryland, RoosterBio provides human bone marrow and adipose-derived MSCs tailored for tissue engineers and cell therapists. The company focuses on streamlining the research process in stem cell commercialization, enabling researchers to conduct high-impact studies more efficiently. RoosterBio's products are designed to assist in the regeneration of tissues and organs while also addressing immune-related diseases. The company has established strategic alliances with organizations like Pall Corporation and Tissue Regeneration Therapeutics Inc.

MicroByre, Inc. is a biotechnology company founded in 2017 and headquartered in Berkeley, California. It specializes in the genetic engineering of non-model micro-species, particularly bacteria that are challenging to manipulate for industrial applications. MicroByre has developed an innovative platform for bacterial domestication, employing an automated characterization pipeline that identifies underutilized bacteria capable of efficiently converting unrefined biomasses into commodity chemicals. This platform leverages a unique dataset to inform minimally precise genetic modifications, enhancing the bacteria's flexibility, yield, and contamination resistance while reducing the need for nutritional additives. By bridging the gap between promising biological research and practical industrial applications, MicroByre positions itself as a valuable partner for various companies seeking to improve their fermentation processes and compete with traditional petrochemical synthesis.

Lumen Bioscience, Inc. is a biotechnology company focused on developing therapeutic biologics for oral delivery. Established in 2017 and based in Seattle, Washington, the company utilizes Spirulina, a blue-green algae, as an industrial-scale production platform for manufacturing high-value molecules. Lumen Bioscience aims to transform the biologics industry by developing biologic drugs more rapidly and cost-effectively than traditional methods. The company offers expertise in synthetic biology, protein design, immunology, bioreactor engineering, and cell physiology, catering to the food, cosmetics, and healthcare sectors. By addressing prevalent diseases that currently lack effective treatments, Lumen Bioscience strives to provide clinicians with innovative therapeutics that were previously inaccessible within the biopharmaceutical landscape.

Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

Riffyn, Inc. is a company that specializes in developing a cloud-based software solution for experimental process design and data analytics, primarily serving the life sciences, pharmaceutical, food, and chemical industries. Its flagship product, Riffyn Nexus, enables researchers to visually design, measure, analyze, and collaborate on experiments through a user-friendly web interface. This innovative platform enhances the planning and learning cycle of scientific research and development by automatically integrating diverse scientific data in real time, facilitating continuous improvement in R&D processes. By overcoming the limitations of traditional electronic lab notebooks and laboratory information management systems, Riffyn Nexus significantly accelerates development cycles and boosts productivity for advanced scientific organizations. Founded in 2014 and headquartered in Oakland, California, Riffyn provides its software solutions along with implementation, change management, and educational services to clients both domestically and internationally.

Arzeda Corporation is a synthetic biology company based in Seattle, Washington, that focuses on the development and manufacture of enzymes and specialty chemical products. Established in 2008, Arzeda employs intelligent protein design technology, integrating physics-based methodologies with artificial intelligence to create innovative designer proteins and enzymes. Its product portfolio caters to various industries, including polymers, pharmaceuticals, and industrial chemicals, enabling clients to access high-performance solutions that also emphasize cost-effectiveness and sustainability.

Riffyn, Inc. is a company that specializes in developing a cloud-based software solution for experimental process design and data analytics, primarily serving the life sciences, pharmaceutical, food, and chemical industries. Its flagship product, Riffyn Nexus, enables researchers to visually design, measure, analyze, and collaborate on experiments through a user-friendly web interface. This innovative platform enhances the planning and learning cycle of scientific research and development by automatically integrating diverse scientific data in real time, facilitating continuous improvement in R&D processes. By overcoming the limitations of traditional electronic lab notebooks and laboratory information management systems, Riffyn Nexus significantly accelerates development cycles and boosts productivity for advanced scientific organizations. Founded in 2014 and headquartered in Oakland, California, Riffyn provides its software solutions along with implementation, change management, and educational services to clients both domestically and internationally.

Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

Riffyn, Inc. is a company that specializes in developing a cloud-based software solution for experimental process design and data analytics, primarily serving the life sciences, pharmaceutical, food, and chemical industries. Its flagship product, Riffyn Nexus, enables researchers to visually design, measure, analyze, and collaborate on experiments through a user-friendly web interface. This innovative platform enhances the planning and learning cycle of scientific research and development by automatically integrating diverse scientific data in real time, facilitating continuous improvement in R&D processes. By overcoming the limitations of traditional electronic lab notebooks and laboratory information management systems, Riffyn Nexus significantly accelerates development cycles and boosts productivity for advanced scientific organizations. Founded in 2014 and headquartered in Oakland, California, Riffyn provides its software solutions along with implementation, change management, and educational services to clients both domestically and internationally.